Ferguson Strategies
Campaign Finance
$118,815 Given
Information
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.
covers through Q3 2012
-
Top Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
-
Republicans vs. Democrats
in dollars -
State vs. Federal
in dollars -
Top PAC Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
Lobbying
$730,000 Income
Information
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
covers roughly through Q3, 2012
Lobbying Carried Out by Ferguson Strategies
-
Names of Lobbyists
-
Client Amount CR Bard Inc $210,000 Public Service Enterprise Group $140,000 Medicines Co $110,000 Eli Lilly & Co $90,000 Novartis Corp $80,000 Celgene Corp $40,000 Merck & Co $40,000 Bode Technology Group $20,000 -
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Taxes,
- Energy & Nuclear Power,
- Finance,
- Manufacturing,
- Medicare & Medicaid,
- Copyright, Patent & Trademark,
- Fed Budget & Appropriations,
- Transportation,
- Defense
-
Most Frequently Disclosed Bills
Bill No. Title H.R.436 Protect Medical Innovation Act of 2011 S.17 Medical Device Access and Innovation Protection Act H.R.910 Energy Tax Prevention Act of 2011 H.R.452 Medicare Decisions Accountability Act of 2011 H.R.2746 Cancer Drug Coverage Parity Act of 2011 S.510 Research of Alcohol Detection Systems for Stopping Alcohol-related Fatalities Everywhere Act of 2011 H.R.1249 America Invents Act H.R.3527 Protecting Main Street End-Users From Excessive Regulation H.R.3208 Patients Come First Act of 2011 H.R.3209 Premarket Predictability Act of 2011 -
Recent Lobbying Contracts
Date Client Summary April 19, 2013 Medicines Co Policy and implementation issues relating to Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Prescription Drug User Fee program; and policy and implementation issues relating to Public Law No. 111-148, the "Patiet Protection and Affordable Care Act." View registration April 19, 2013 US Healthcare Supply, LLC Reimbursement issues relating to durable medical equipment suppliers, including policy issues relating to the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) competitive bidding program. View registration April 19, 2013 Prudential Financial, Inc. Policy issues relating to financial services and corporate and individual tax reform. View registration
